Application 021749
- Type
- NDA
- Sponsor
- HAMELN PHARMA PLUS
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | PENTETATE CALCIUM TRISODIUM | PENTETATE CALCIUM TRISODIUM | SOLUTION;INHALATION, INTRAVENOUS | EQ 1GM BASE/5ML (EQ 200MG BASE/ML) | Yes | Yes |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 70651-001 | Pentetate calcium trisodium | pentetate calcium trisodium | hameln pharma gmbh | NDA | Current |
| 70651-001 | Pentetate calcium trisodium | pentetate calcium trisodium | hameln pharma plus gmbh | NDA | Current |
| 70651-001 | Pentetate calcium trisodium | pentetate calcium trisodium | hameln pharma plus gmbh | NDA | Current |
Documents#
Document, Submission type, Date table| Document | Submission type | Date |
|---|
| 16303 | SUPPL | 2013-03-26 |
| 6113 | SUPPL | 2013-03-22 |
| 6112 | SUPPL | 2005-08-08 |
| 42297 | ORIG | 2004-10-20 |
| 44149 | ORIG | 2004-08-11 |
| 37578 | ORIG | 2004-08-11 |
| 28516 | ORIG | 2004-08-11 |
| 24008 | ORIG | 2004-08-11 |